Single cell Whole genome sequencing in peripheral
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) NHLBI, under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation for Single cell Whole genome sequencing in peripheral blood of patients with VEXAS syndrome. This opportunity seeks to acquire services or equipment related to this specialized sequencing. Proposals are due February 5, 2026.
Scope of Work
The requirement is for Single cell Whole genome sequencing in peripheral blood of patients with VEXAS syndrome. This involves advanced laboratory services or equipment to perform whole genome sequencing at a single-cell resolution on blood samples from patients diagnosed with VEXAS syndrome.
Contract & Timeline
- Type: Combined Synopsis/Solicitation
- Set-Aside: None specified
- Product/Service Code: 6640 (Laboratory Equipment And Supplies)
- Proposal Due: February 5, 2026, at 7:00 PM ET
- Published: January 28, 2026
Additional Information
For further details or to submit a proposal, interested parties should refer to the full solicitation document. Primary Point of Contact: Roxane Burkett, burkettr@nhlbi.nih.gov, +1 301 435 6671.